The Global Bioburden Testing Market has experienced consistent growth, with a compound annual growth rate (CAGR) of 12-15%. This growth is driven by tightening regulatory standards and an increasing ...

The Pharmaceutical Industry has a diverse set of products all with varying level of microbial risk to patients. On the low risk extreme there are topical pharmaceuticals on the other extreme are the ...

Dublin, Nov. 21, 2024 (GLOBE NEWSWIRE) -- The "Bioburden Testing Market Size, Share and Trends Analysis Report by Product (Consumables, Instruments), Test, Application, End-use, and Region 2024-2030" ...

Methods to Simultaneously Reduce Bioburden and Maintain Column Integrity, Explained Continuous bioprocessing is inevitably becoming the future of biomanufacturing. To date, several steps within a ...

Note: This article is based on the white paper "Establishing Bioburden Alert and Action Levels" available for download. Most national and international standards regarding bioburden, sterilization, or ...

Merck has launched its latest pharmaceutical bioburden and water testing product, the Milliflex Oasis® System. The system had 96 new features, which are designed to provide benefits such as: ...

On May 26, 2020, the U.S. Food and Drug Administration (“FDA” or “Agency”) issued an immediately in effect guidance, Recommendations for Sponsors Requesting EUAs for Decontamination and Bioburden ...

Microbial identity data can be critical for determining contamination sources. In bio/pharmaceutical manufacturing, monitoring the bioburden of raw materials, intermediates, drug substances, ...

Marketresearch.biz reports that the Bioburden Testing Market size is expected to be worth around USD 4.93 Billion by 2033, from USD 1.35 Billion in 2023, growing at a CAGR of 14.20% during the ...

Merck has launched its latest pharmaceutical bioburden and water testing product, the Milliflex Oasis® System. The system had 96 new features, which are designed to provide benefits such as: ...